AstraZeneca: India’s drug regulator orders withdrawal of AstraZeneca’s cancer drug due to potential adverse effects |
The Drug Controller General of India (DCGI) has asked all state drug regulators to withdraw AstraZeneca‘s anti-cancer drug Olaparib tablets. This drug which is mostly used for the treatment of …